Search results
Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma. Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing this protein and cell therapy CDMO.
Umoja’s world-class team of scientists, researchers, and drug development experts are united by our shared goal of unlocking the true potential of CAR T cell therapies.
Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma. Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing a protein and cell therapy CDMO.
Development and manufacturing are core competencies of Umoja, which ensures that our treatments are widely accessible and cost-effective. Led by Ryan Crisman, Umoja’s Co-founder and Chief Technology Officer, Umoja is pioneering best-in-class development and manufacturing capabilities.
Aug 30, 2021 · Umoja is “rethinking the supply chain of CAR-T therapies from the ground up,” chief technical officer Ryan Crisman said in the release. The company hopes to eliminate costly, time-consuming...
- Kevin Dunleavy
Oct 26, 2022 · Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma. Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing this protein and cell therapy CDMO.
Nov 1, 2022 · Ryan Crisman is the co-founder and Chief Technical Officer at Umoja Biopharma. Before starting Umoja in 2019, Ryan served as the Executive Director for the Gates Biomanufacturing Facility, where he was responsible for building out and staffing this protein and cell therapy CDMO.
